21
A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection
Condition(s): Hepatitis C Last Updated: June 3, 2011Completed
96 Clinical Trials for: PEG-IFN Alfa-2a, Placebo, Page 2 of 5
Hide Studies Not Seeking New Volunteers
22
Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients
Condition(s): Depression Last Updated: March 20, 2013Completed
23
Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection
Condition(s): HCV Infection Last Updated: June 7, 2012Active, not recruiting
24
A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.
Condition(s): Hepatitis B, Chronic Last Updated: January 18, 2011Withdrawn
25
VX-950-TiDP24-C216: A Safety and Efficacy Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment
Condition(s): Hepatitis C, Chronic Last Updated: July 18, 2011Completed
26
Boceprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Participants With Chronic Hepatitis C Genotype 1 Who Failed Prior Treatment With Peginterferon/Ribavirin (Study P05685AM2)(COMPLETED)
Condition(s): Hepatitis C, Chronic Last Updated: December 30, 2011Completed
27
Study of SCY-635, Pegasys and Copegus in Hepatitis C
Condition(s): Hepatitis C Infection Last Updated: May 29, 2012Completed
28
TMC435HPC3007 - Phase III Trial of TMC435 in Genotype 1 Hepatitis C-infected Patients Who Relapsed After Previous Therapy
Condition(s): Hepatitis C Last Updated: February 26, 2013Completed
29
TMC435-TiDP16-C208 - Phase III Trial of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients
Condition(s): Hepatitis C Last Updated: February 21, 2013Completed
30
Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV
Condition(s): Hepatitis C; HIV Infections Last Updated: December 18, 2012Completed
31
A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C
Condition(s): Hepatitis C Last Updated: June 22, 2011Completed
32
GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus
Condition(s): Hepatitis C, Chronic Last Updated: March 7, 2013Active, not recruiting
33
A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
Condition(s): Hepatitis C, Chronic Last Updated: May 7, 2013Completed
34
Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin
Condition(s): Hepatitis C Virus Last Updated: June 18, 2012Active, not recruiting
35
Study of BMS-790052 Add-On to Standard of Care in Treatment Naive Subjects
Condition(s): Hepatitis C Virus Last Updated: March 28, 2013Completed
36
Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia
Condition(s): Hepatitis C Infection; Thrombocytopenia Last Updated: November 29, 2012Recruiting
37
Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
Condition(s): Chronic Hepatitis C Last Updated: June 22, 2011Completed
38
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B
Condition(s): Hepatitis B, Chronic Last Updated: May 7, 2013Active, not recruiting
39
TMC435-TiDP16-C205: A Phase II Study of TMC435 in Combination With Pegylated Interferon Alpha-2a and Ribavirin in Patients Infected With Genotype 1 Hepatitis C Virus Who Never Received Treatment
Condition(s): Hepatitis C Last Updated: June 28, 2012Completed
40
Pharmacokinetics of Multiple Ascending Doses of VCH-222 in Subjects With Chronic Hepatitis C Infection
Condition(s): Hepatitis C Last Updated: October 8, 2012Completed
